Involvement of antibody-dependent apoptosis in graft rejection

Transplantation

Volumn 69, Issue 12, 2000, Pages 2601-2608

  Plissonnier, Didier ^b   Henaff, Morgana ^a   Poncet, Pascal ^a   Paris, Estelle ^b   Tron, François ^b   Thuillez, Christian ^b   Michel, Jean Baptiste ^a  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN BINDING; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE; GRAFT REJECTION; GRAFT SURVIVAL; HEART MUSCLE CELL; HEART TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034720784     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006270-00021     Document Type: Article

References (30)

1. Häyri P. Chronic rejection: an update on the mechanism. Transplant Proc 1998; 30: 3393.
2. Demetris AJ, Murase N, Lee RG, et al. Chronic rejection: a general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allograft. Ann Transplant 1997; 2: 27.
3. Schmitz-Rixen T, Megerman J, Colvin RB, et al. Immunosuppressive treatment of aortic allografts. J Vasc Surg 1988; 7: 82.
4. Plissonnier D, Levy BI, Salzmann JL, Nochy D, Watelet J, Michel JB. Allograft-induced arterial wall injury and response in normotensive and spontaneously hypertensive rats. Arterioscler Thromb 1991; 11: 1690.
5. Plissonnier D, Nochy D, Poncet P, et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 1995; 60: 414.
6. Kolb F, Heudes D, Mandet C, et al. Presensitization accelerates allograft arteriosclerosis. Transplantation 1996; 62: 1401.
7. Battle T, Arnal JF, Challah M, Michel JB. Selective isolation of rat aortic wall layers and their cell types in culture: application to converting enzyme activity measurement. Tissue Cell 1994; 26: 943.
8. Duijvestin AM, Van Groor H, Klatter F, Majoor G, Van Bussel E, Van Breda Vriesman PJC. Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 1992; 66: 459.
9. Gabbiani G, Schmid E, Winter S, et al. Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci USA 1981; 78: 298.
10. Wittenberg BA, White RL, Ginzberg O, Spray DC. Effect of calcium on the dissociation of the mature rat heart into individual and paired myocytes: electrical properties of cell pairs. Circ Res 1986; 59: 143.
11. Zaer F, Metz S, Scornik JC. Antibody screening by enzyme-linked immunosorbent assay using pooled soluble HLA in renal transplant candidates. Transplantation 1997; 63: 48.
12. Schonemann C, Groth J, Leverenz S, May G. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance. Transplantation 1998; 65: 1519.
13. Worthington JE, Thomas AA, Dyer PA, Martin S. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome. Transplantation 1998; 65: 121.
14. Reed EF, Hong B, Ho E, Harris PE, Weinberger J. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation 1996; 61: 566.
15. Lajoie G. Antibody-mediated rejection of human renal allografts: an electron microscopic study of peritubular capillaries. Ultrastruct Pathol 1997; 21: 235.
16. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
17. Russell PS, Chase CM, Colvin RB. Alloantibody-and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 1997; 64: 1531.
18. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392.
19. Shi C, Feinberg MW, Zhang D, et al. Donor MHC and adhesion molecules in transplant arteriosclerosis. J Clin Invest 1999; 103: 469.
20. Dong C, Wilson JE, Winters GL, McManus BM. Human transplant coronary artery disease: pathological evidence for Fasmediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest 1996; 74: 921.
21. Laine J, Etelämäki P, Holmberg C, Dunkel L. Apoptotic cell death in human chronic renal allograft rejection. Transplantation 1997; 63: 101.
22. Bergese SD, Klenotic SM, Wakely ME, Sedmak DD, Orosz CG. Apoptosis in murine cardiac grafts. Transplantation 1997; 63: 320.
23. Akyürek LM, Johnsson C, Lange D, et al. Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants: influence of Fas-mediated apoptosis. J Clin Invest 1998; 101: 2889.
24. Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science 1991; 252: 1424.
25. Skov S, Klausen P, Claesson MH. Ligation of major histocompatibility complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis. J Cell Biol 1997; 139: 1523.
26. Genestier L, Prigent AF, Paillot R, et al. Caspase-dependent ceramide production in Fas-and HLA class I-mediated peripheral T cell apoptosis. J Biol Chem 1998; 273: 5060.
27. Genestier L, Paillot R, Bonnefoy-Berard N, et al. Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I α1 domain. Blood 1997; 90: 3629.
28. Woodle ES, Smith DM, Bluestone JA, Kirkman WM, Green DR, Skowronski EW. Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathway. J Immunol 1997; 158: 2156.
29. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251.
30. Schierle GS, Hansson O, Leist M, Nicotera P, Widner H, Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 1999; 5: 97.